The caretaker federal government announced increased prices for 146 life-saving drugs, citing global raw material cost surges. This decision, aimed at managing the impact of inflation, was endorsed by the federal cabinet led by interim Prime Minister Anwaarul Haq Kakar.
Government Measures and International Cooperation
Efforts to mitigate medicine shortages include bolstering the Drug Regulatory Authority of Pakistan (DRAP) and tackling the illegal medicine trade. Additionally, the cabinet approved international agreements to foster collaboration in competition regulation and recognized Pakistani professionals’ international achievements.
The government’s price adjustment affects essential medications amidst rising global costs. It endeavours to balance public access to affordable medicines with pharmaceutical industry growth. The strategy includes enhancing regulatory performance and combating illegal activities in the drug market. Meanwhile, international memorandums aim to share knowledge and acknowledge Pakistani citizens’ global contributions.
